Although NEAT1-c-Met signaling is known to play a role in several cancers [35, 36], our findings are the first indication that NEAT1 contributes the progression of RCC through the miR-34a/c-Met axis. This evidence concerns the gene NEAT1 and renal cell carcinoma.